Cytori Therapeutics (CYTX) Data from RESTORE-2 Study of Celution(R) System
March 2nd, 2011
No comments
Results from a EU breast reconstruction trial using a new minimally invasive procedure Read more…
Categories: Cytori Therapeutics, NASDAQ: CYTX, RESTORE-2 study, Stem Cell Research
